Effects of ginsenoside Rh2(GS-Rh2) on cell cycle of Eca-109 esophageal carcinoma cell line

Zhongguo Zhongyao Zazhi

Volumn 30, Issue 20, 2005, Pages 1617-1621

  Li, Li ^a   Qi, Feng Ying ^a   Liu, Jun Ru ^a   Zuo, Lian Fu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

CDK 2; Cell cycle; CyclinE; Esophageal carcinoma; Ginsenoside Rh2; p21WAF1

Indexed keywords

CDK2 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN E; GINSENOSIDE; GINSENOSIDE RH 2; HERBACEOUS AGENT; MESSENGER RNA;

ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; ESOPHAGUS TUMOR; GENETICS; GINSENG; HUMAN; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ESOPHAGEAL NEOPLASMS; GINSENOSIDES; HUMANS; PANAX; PLANTS, MEDICINAL; RNA, MESSENGER; TIME FACTORS;

EID: 33751278006     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Yun T K, Lee Y S, Lee Y H, et al. Anticarcinogenic effect of Panax ginseng C. A. meyer and identification of active compounds. J Korean Med Sci, 2001, 16(suppl): S6.
2. 2 in SMMC-7721 hepatocarcinoma cell line. Pharmacol Toxicol, 2003, 93(6): 275.
3. 2. J Biochem Cell Biol, 1998, 30(3): 327.
4. 2 in human blood lymphocytes. Cancer Res, 1995, 55(6): 1221.
5. 2-induced apoptosis. Conor Lett, 1997, 121(1): 73.
6. 2 on tumor growth in nude mice bearing human ovarian cancer cells. J Cancer Res, 1998, 89(7): 733.
7. 1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett, 1996, 110(1-2): 193.
8. Farley J, Smith L M, Darcy KM, et al. CyclinE expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: A gynecologic oncology group study. Cancer Res, 2003, 63(6): 1235.